Neurogene Inc. (NGNE) Institutional Ownership

Ownership Summary

The institutional landscape for Neurogene Inc. (NASDAQ:NGNE) includes 92 filers as of the latest reporting cycle ending December 2025.

• Institutional ownership in Neurogene edged up to 78.0% in December 2025, compared to 72.2% in September 2025.
• Institutional share ownership changed by 10.08% QoQ, while the number of institutional owners saw an increase of 3.37% YoY.
• The latest 13F cycle for Neurogene reveals that of 92 total investors, 38 funds grew their exposure, whereas 29 reduced theirs and 25 made no changes.
• The total number of shares held by institutions in Neurogene increased to 16.51Mn as of December 2025, a net change of up by 1.51Mn shares quarter on quarter, and up 379.81K shares year over year.
• Samsara BioCapital, LLC continues to be the largest institutional holder of Neurogene as of December 31, 2025, with a position of 1.72Mn shares, representing 8.11% of the company's outstanding stock.
• Among the most significant buyers of Neurogene during December 2025 were Trails Edge Capital Partners, LP (785.00K), CITADEL ADVISORS LLC (364.23K), Logos Global Management LP (195.00K), Redmile Group, LLC (160.58K), JENNISON ASSOCIATES LLC (139.00K).
• Leading sellers of Neurogene stock in December 2025 included MILLENNIUM MANAGEMENT LLC (176.54K), GREAT POINT PARTNERS LLC (96.81K), BALYASNY ASSET MANAGEMENT L.P. (90.42K), UBS Group AG (73.59K), DEUTSCHE BANK AG\ (66.71K).
• The top 10 institutional holders of Neurogene for the quarter ending December 2025 included Samsara BioCapital, LLC (1.72Mn), Redmile Group, LLC (1.46Mn), RTW INVESTMENTS, LP (1.36Mn), Casdin Capital, LLC (1.30Mn), EcoR1 Capital, LLC (1.27Mn), BAKER BROS. ADVISORS LP (991.69K), BlackRock, Inc. (945.58K), Trails Edge Capital Partners, LP (785.00K), TORONTO DOMINION BANK (681.34K), VANGUARD GROUP INC (656.57K).